Loading this company
Loading this company
Too wide to call. Our lenses land between $25.37 and $191.62, which is too broad to say where today’s price sits in it.
$131.12USD up +$0.69 (+0.53%)
Quoted · Prices are delayed.
Showing the last price we hold for this listing, recorded 2026-10-19 15:46 UTC (6 hours ago).
Nothing we can cite explains today’s move for this company.
Our range from 4 models, on today’s numbers
$25.37–$191.62
What the price needs: revenue growth of 24.6%/yr for 5 years (our model assumes 8.5%).
Led by discounted cash flow (DCF) · Dividend income business
Price $131.12Priced · Prices are delayed.
Our forward range over 12 months is part of Pro. See plans
Analysts’ mean target
$154.00 across 11 analysts
The high and low of the analyst range is part of Pro. See plans
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It operates in the Medical Instruments & Supplies industry (Healthcare sector), headquartered in United States. The company employs roughly 15,500 people.
Prices are delayed. The feed does not say when these figures were taken.
No recent headlines we can cite for this company.
The 90-day buying-and-selling read is part of Pro. See plans
Not investment advice. TickerWorth Score is a model output.
The score, the fair value and the reverse DCF are free on every company. Pro lets you change growth, margin and the discount rate yourself, see every valuation lens and its working, and download the model. Start a 7-day free trial — a card is required and you can cancel any time before it ends. $99 a year, or $14.99 monthly.